David Easterhoff

Company: Moderna

Job title: Director, Immune Therapeutics Discovery

Seminars:

Exploring the Use of mRNA-LNP for Antigen-Specific Immune Tolerance 9:00 am

Focusing on the mRNA and LNP to identify an optimal drug product for inducing antigen-specific tolerance Highlighting the influence of the antigen on T-cell fate outcomes Interrogating what target product profile may be achievableRead more

day: Conference Day Two